Advanced Filters
noise

Depression Clinical Trials

A listing of Depression medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 1,234 clinical trials
J Joanne V Loewy, DA, LCAT, MT-BC

Assessment of Music Experiences in Navigating Depression Part 2

This study is again looking at the use of music and music therapy experiences in navigating depression. The researchers will provide 11 sessions of music therapy and half will be followed by recitals at the Third Street School Music Settlement where the kids enrolled in our study will observe and …

7 - 15 years of age All Phase N/A
J Joshua Brown, MD, PhD

Pharmacologic Augmentation of TMS for Depression With D-serine

The goal of this study is to test whether combining D-serine with 30 treatments of a) iTBS and b) 18-Hz protocols will enhance clinical outcomes compared to rTMS with placebo (i.e., sugar pill). The investigators hypothesize that NMDA receptor activation via D-serine combined with repeated sessions of rTMS will produce …

18 - 80 years of age All Phase 1
Y Young Kim-wan, PhD

Efficacy of Narrative Therapy for Older People With Depression

The research aims to investigate the efficacy of a narrative therapy group in reducing depressive symptoms among older people. This study adopts a mixed methods research design, involving both quantitative and qualitative approaches. In the quantitative study, a randomised controlled trial will compare a narrative therapy group with a waitlist …

60 years of age All Phase N/A
K Kangguang Lin, Ph.D; MD

Treating Loneliness In The Older Adult With Depression With tDCS

High loneliness is prevalent among older adults and is a significant risk factor for major depression and low recovery rates in patients. Current interventions for loneliness are limited. Previous research has demonstrated a link between loneliness, negative social emotions, and reduced resting-state functional connectivity in the lateral prefrontal cortex (LPFC) …

60 - 80 years of age All Phase N/A
R Reyhan Ilhan, MS.

Neurobiological and Genomic Predictors of Relapse in Depression

The goal of this observational study is to test whether the discontinuation of antidepressant medications for patients with depression can be decided after the normalization of biological parameters. The main questions it aims are: When patients with depression treated with antidepressants, does their brain activity also become normal? If so, …

18 - 65 years of age All Phase N/A

Sleep Modulation to Treat Depression

Current first-line treatments for major depression (antidepressants and psychotherapy) show a long latency to response, and less than half of all patients experience full remission with optimized treatment, indicating the need for new developments. The aim of this study is to extend and further develop a longstanding line of research …

30 - 60 years of age All Phase N/A
S Sarah E Knarr

Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Stage II

The investigators hypothesize that brief behavioral therapy and targeted propofol infusion in depressed geriatric patients will augment subsequent slow wave sleep and improve clinical and cognitive outcomes. The team will recruit 70 participants for a double-blinded placebo controlled randomized controlled trial. Two propofol infusions, 2-6 days apart, will be administered, …

60 years of age All Phase 2
J Jonathan P Roiser, PhD

Mechanisms Underlying Antidepressant Effects of Physical Activity

It is well established that any level of physical activity can help prevent and treat depression, with more strenuous activity having a greater effect. Understanding the mechanisms driving this antidepressant effect is important because it could allow exercise programmes to be made more effective, accessible, and targeted. Such knowledge could …

18 - 60 years of age All Phase N/A
M Manuel Morrens

INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder

This is a randomised, double-blind, placebo-controlled clinical trial in which patients with major depressive disorder will receive augmentation through minocycline (MCO), celecoxib (CXB) or placebo.

18 - 65 years of age All Phase 3
P Phern Chern Tor, MBBS

A Novel Individualized Connectome-guided Approach for Precision Intermittent Theta Burst Stimulation for Depression

The Investigators propose to carry out a randomized, double-blind trial to compare the clinical efficacy of an individualized connectome-guided accelerated iTBS vs an anatomically-guided (Beam F3) accelerated iTBS. The study team will recruit both inpatients and outpatients who had been referred for TMS for the treatment of depression.

21 years of age All Phase N/A

Simplify language using AI